Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport for Idiopathic Overactive Bladder
NCT00578097Phase 2Terminated
- Sponsor
- Ipsen
- Start
- Feb 2008
- Primary completion
- Jun 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 8
01
Overview
A Phase 2 trial of abobotulinumtoxinA in overactive bladder (OAB), sponsored by Ipsen. Started Feb 2008; status: terminated.
02
Drugs
abobotulinumtoxinA
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00578097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00578097.